Fig. 4From: PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patientsPDXGEM for gemcitabine in pancreatic cancer patients. a-d Kaplan-Meier curves of overall survival between pancreatic cancer patients with a higher (gray) and lower (black) PDXGEM score than the median prediction score in (a) GSE57495, (b) M-MEXP-2780, (c) GSE17891, and (d) ICGC cohort. P-value was calculated using log-rank testBack to article page